Corrigendum: Cost and complications of local therapies for early-stage breast cancer (Journal of the National Cancer Institute (2017) 109:1 DOI: 10.1093/jnci/djw178);Cost and complications of local therapies for early-stage breast cancer

Journal of the National Cancer Institute

Volumn 109, Issue 1, 2017, Pages

  Smith, Benjamin D ^a,b   Jiang, Jing ^b   Shih, Ya Chentina ^b   Giordano, Sharon H ^a,b   Huo, Jinhai ^b   Jagsi, Reshma ^c,d   Momoh, Adeyiza O ^d   Caudle, Abigail S ^a   Hunt, Kelly K ^b   Shaitelman, Simona F ^a   Buchholz, Thomas A ^a   Shirvani, Shervin M ^a,e  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Department of Surgical Oncology ^*  (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e Banner MD Anderson Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST CANCER; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COMPLICATION; DEVICE REMOVAL; EARLY CANCER; EXTERNAL BEAM RADIOTHERAPY; FAT NECROSIS; FEMALE; GRAFT DYSFUNCTION; HEALTH CARE COST; HEMATOMA; HUMAN; INFECTIOUS COMPLICATION; LOCAL THERAPY; LUMPECTOMY; MAJOR CLINICAL STUDY; MASTALGIA; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION PNEUMONIA; RIB FRACTURE; SEROMA; WOUND COMPLICATION;

EID: 85014813207     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djy135     Document Type: Erratum

References (36)

1. Young RC. Value-based cancer care. N Engl J Med. 2015;373(27):2593-2595.
2. Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477-2481.
3. de Souza JA, Ratain MJ, Fendrick AM. Value-based insurance design: aligning incentives, benefits, and evidence in oncology. J Natl Compr Canc Netw. 2012; 10(1):18-23.
4. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016; 66(1):7-30.
5. SEER Stat Fact Sheet: Breast Cancer. http://seer.cancer.gov/statfacts/html/ breast.html. Accessed January 3, 2016.
6. Gradishar WJ, Anderson BO, Balassanian R, et al. Breast Cancer Version 2.2015. J Natl Compr Canc Netw. 2015;13(4):448-475.
7. Jagsi R, Jiang J, Momoh AO, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014;32(9):919-926.
8. Fisher CS, Martin-Dunlap T, Ruppel MB, et al. Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age. Ann Surg Oncol. 2012;19(10): 3246-3250.
9. Lee CN, Chang Y, Adimorah N, et al. Decision making about surgery for earlystage breast cancer. J AmColl Surg. 2012;214(1):1-10.
10. Albornoz CR, Matros E, Lee CN, et al. Bilateral mastectomy versus breastconserving surgery for early-stage breast cancer: The role of breast reconstruction. Plast Reconstr Surg. 2015;135(6):1518-1526.
11. Litiere S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412-419.
12. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567-575.
13. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 Suppl):IV-3-18.
14. Nattinger AB, Laud PW, Bajorunaite R, et al. An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Health Serv Res. 2004;39(6 Pt 1):1733-1749.
15. Gold HT, Do HT. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data. Health Serv Res. 2007;42(5):2056-2069.
16. Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471-1474.
17. Smith GL, Xu Y, Buchholz TA, et al. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA. 2012;307(17):1827-1837.
18. Jagsi R, Jiang J, Momoh AO, et al. Complications after mastectomy and immediate breast reconstruction for breast cancer: A claims-based analysis. Ann Surg. 2016;263(2):219-227.
19. Smith GL, Jiang J, Buchholz TA, et al. Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: Impact of patient stratification on breast preservation. Int J Radiat Oncol Biol Phys. 2014;88(2):274-284.
20. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690-1691.
21. Huo J, Giordano SH, Smith BD, et al. Contemporary toxicity profile of breast brachytherapy versus external beam radiation after lumpectomy for breast cancer. Int J Radiat Oncol Biol Phys. 2016;94(4):709-718.
22. Warren JL, Brown ML, Fay MP, et al. Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J Clin Oncol. 2002; 20(1):307-316.
23. Barlow WE, Taplin SH, Yoshida CK, et al. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. J Natl Cancer Inst. 2001;93(6):447-455.
24. Fischer JP, Fox JP, Nelson JA, et al. A longitudinal assessment of outcomes and healthcare resource utilization after immediate breast reconstructioncomparing implant-and autologous-based breast reconstruction. Ann Surg. 2015;262(4):692-699.
25. Israeli R, Funk S, Reaven NL. Comparative analysis of 18-month outcomes and costs of breast reconstruction flap procedures. Plast Reconstr Surg. 2014; 133(3):471-479.
26. Deshmukh AA, Cantor SB, Crosby MA, et al. Cost of contralateral prophylactic mastectomy. Ann Surg Oncol. 2014;21(9):2823-2830.
27. Mahmood U, Hanlon AL, Koshy M, et al. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol. 2013; 20(5):1436-1443.
28. Dragun AE, Huang B, Tucker TC, et al. Increasing mastectomy rates among all age groups for early stage breast cancer: A 10-year study of surgical choice. Breast J. 2012;18(4):318-325.
29. Dragun AE, Pan J, Riley EC, et al. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: A 14-year report from a comprehensive cancer center. Am J Clin Oncol. 2013; 36(4):375-380.
30. Katipamula R, Degnim AC, Hoskin T, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27(25):4082-4088.
31. McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16(10):2682-2690.
32. Kummerow KL, Du L, Penson DF, et al. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. 2015;150(1):9-16.
33. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513-520.
34. Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086-1094.
35. Shaitelman SF, Schlembach PJ, Arzu I, et al. Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: A randomized clinical trial. JAMA Oncol. 2015;1(7):931-941.
36. Bekelman JE, Sylwestrzak G, Barron J, et al. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013. JAMA. 2014;312(23):2542-2550.